Component
Pancreatic beta cell mass
Pancreatic beta cell mass. Species, exposure and limitations are retained in each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
Where it participates (unsigned role)
Unlike in adult brain or islet alpha-cells in which GABA exerts hyperpolarizing effects, in islet beta-cells GABA produces membrane depolarization and calcium influx leading to the activation of PI3-kinase and Akt-dependent growth and survival pathways, this provides a potential mechanism underlying findings that GABA therapy preserves beta-cell mass and prevents the development of type 1 diabetes, remarkably in severely diabetic mice GABA restores beta-cell mass and reverses the disease, and GABA suppresses insulitis and systemic inflammatory cytokine production.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/gaba-research/21709230.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "926bc916592c55cf6089bcb240ec5545e0ff3850e6d927bb82efacfc61841175", "start_char": 0, "end_char": 1117, "text_sha256": "926bc916592c55cf6089bcb240ec5545e0ff3850e6d927bb82efacfc61841175"}
- experimental_model
- Islet cell electrophysiology and signalling with GABA therapy in diabetes-prone and severely diabetic mice
- exposure
- GABA given therapeutically, with membrane potential, calcium influx and survival pathway readouts in beta cells
- limitations
- A mouse therapy study. Its electrophysiological claim about beta cells is stated as a contrast with alpha cells and brain rather than shown alongside a measured chloride gradient.
- nutrient_topic
- GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. · Gamma-aminobutyric acid
- organism
- Mouse
- plain_language
- In the insulin-producing cell the same molecule does the opposite of what it does in the brain, and the cells survive better for it.
- primary_references
- [gb-p21709230] GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. (2011). https://pubmed.ncbi.nlm.nih.gov/21709230/ DOI: 10.1073/pnas.1102715108
- tissue_or_cell_type
- Pancreatic islet and immune system
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Islet cell electrophysiology and signalling with GABA therapy in diabetes-prone and severely diabetic mice · source_derived_draft · unverified_draft
### gb-gaba-depolarises-the-beta-cell Unlike in adult brain or islet alpha-cells in which GABA exerts hyperpolarizing effects, in islet beta-cells GABA produces membrane depolarization and calcium influx leading to the activation of PI3-kinase and Akt-dependent growth and survival pathways, this provides a potential mechanism underlying findings that GABA therapy preserves beta-cell mass and prevents the development of type 1 diabetes, remarkably in severely diabetic mice GABA restores beta-cell mass and reverses the disease, and GABA suppresses insulitis and systemic inflammatory cytokine production. Condition category: normal nutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. plain_language: In the insulin-producing cell the same molecule does the opposite of what it does in the brain, and the cells survive better for it. organism: Mouse tissue_or_cell_type: Pancreatic islet and immune system experimental_model: Islet cell electrophysiology and signalling with GABA therapy in diabetes-prone and severely diabetic mice limitations: A mouse therapy study. Its electrophysiological claim about beta cells is stated as a contrast with alpha cells and brain rather than shown alongside a measured chloride gradient. exposure: GABA given therapeutically, with membrane potential, calcium influx and survival pathway readouts in beta cells evidence_span: {"source_cache": "artifacts/gaba-research/21709230.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "926bc916592c55cf6089bcb240ec5545e0ff3850e6d927bb82efacfc61841175", "start_char": 0, "end_char": 1117, "text_sha256": "926bc916592c55cf6089bcb240ec5545e0ff3850e6d927bb82efacfc61841175"} [gb-p21709230] GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. (2011). https://pubmed.ncbi.nlm.nih.gov/21709230/ DOI: 10.1073/pnas.1102715108
Complete structured claim and evidenceGABA was identified as an inducer of alpha-to-beta-like cell conversion in vivo, this conversion induces alpha cell replacement mechanisms through the mobilization of duct-lining precursor cells that adopt an alpha cell identity prior to being converted into beta-like cells solely upon sustained GABA exposure, these neo-generated beta-like cells are functional and can repeatedly reverse chemically induced diabetes in vivo, and similarly the treatment of transplanted human islets with GABA results in a loss of alpha cells and a concomitant increase in beta-like cell counts suggestive of alpha-to-beta-like cell conversion processes also in humans.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/gaba-research/27916274.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4be6f165f91fed2e5ce13c111ae778fef006821e139b2702a3833f5924a4fffd", "start_char": 0, "end_char": 1087, "text_sha256": "4be6f165f91fed2e5ce13c111ae778fef006821e139b2702a3833f5924a4fffd"}
- experimental_model
- Lineage tracing and functional testing in mice with sustained GABA exposure, and treatment of transplanted human islets
- exposure
- Sustained long-term GABA administration in vivo, and GABA treatment of transplanted human islets
- limitations
- The human component is transplanted islets rather than people, and the cell counts are suggestive of conversion rather than a lineage trace in human tissue.
- nutrient_topic
- GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. · Gamma-aminobutyric acid
- organism
- Mouse
- plain_language
- Given long enough, the molecule appeared to turn one islet cell type into the other, repeatedly reversing diabetes in mice.
- primary_references
- [gb-p27916274] Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis. (2017). https://pubmed.ncbi.nlm.nih.gov/27916274/ DOI: 10.1016/j.cell.2016.11.002
- tissue_or_cell_type
- Pancreatic islet and duct
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Lineage tracing and functional testing in mice with sustained GABA exposure, and treatment of transplanted human islets · source_derived_draft · unverified_draft
### gb-sustained-gaba-makes-new-beta-like-cells GABA was identified as an inducer of alpha-to-beta-like cell conversion in vivo, this conversion induces alpha cell replacement mechanisms through the mobilization of duct-lining precursor cells that adopt an alpha cell identity prior to being converted into beta-like cells solely upon sustained GABA exposure, these neo-generated beta-like cells are functional and can repeatedly reverse chemically induced diabetes in vivo, and similarly the treatment of transplanted human islets with GABA results in a loss of alpha cells and a concomitant increase in beta-like cell counts suggestive of alpha-to-beta-like cell conversion processes also in humans. Condition category: normal nutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. plain_language: Given long enough, the molecule appeared to turn one islet cell type into the other, repeatedly reversing diabetes in mice. organism: Mouse tissue_or_cell_type: Pancreatic islet and duct experimental_model: Lineage tracing and functional testing in mice with sustained GABA exposure, and treatment of transplanted human islets limitations: The human component is transplanted islets rather than people, and the cell counts are suggestive of conversion rather than a lineage trace in human tissue. exposure: Sustained long-term GABA administration in vivo, and GABA treatment of transplanted human islets evidence_span: {"source_cache": "artifacts/gaba-research/27916274.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4be6f165f91fed2e5ce13c111ae778fef006821e139b2702a3833f5924a4fffd", "start_char": 0, "end_char": 1087, "text_sha256": "4be6f165f91fed2e5ce13c111ae778fef006821e139b2702a3833f5924a4fffd"} [gb-p27916274] Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis. (2017). https://pubmed.ncbi.nlm.nih.gov/27916274/ DOI: 10.1016/j.cell.2016.11.002
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.